Evidence map›Paper›PMID 35654801›Full record

ArticleScientific data2022

CDCDB: A large and continuously updated drug combination database.

Guy Shtar, Louise Azulay, Omer Nizri, Lior Rokach, Bracha Shapira

Open access · goldAbstract readDataset
In one paragraph

Article in Scientific data, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. A Hypergraph-Based Model for Predicting Potential Drug Combinations in Cancer Therapy.Interdisciplinary sciences, computational life sciences · 2026
    Article
  2. Review
  3. A Knowledge Graph Approach To Discovering Drug Combination Therapies Across The Phenome.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Guy ShtarBen-Gurion University of the Negev, Department of Software and Information Systems Engineering, Beer-Sheva, 8410501, Israel. shtar@post.bgu.ac.il.ORCID 0000-0003-0647-8753
Louise AzulayUniversidade Federal Fluminense, Instituto de Biologia, Niterói, 24220900, Brazil.
Omer NizriBen-Gurion University of the Negev, Department of Software and Information Systems Engineering, Beer-Sheva, 8410501, Israel.
Lior RokachBen-Gurion University of the Negev, Department of Software and Information Systems Engineering, Beer-Sheva, 8410501, Israel.
Bracha ShapiraBen-Gurion University of the Negev, Department of Software and Information Systems Engineering, Beer-Sheva, 8410501, Israel.
Ben-Gurion University of the Negev · ILUniversidade Federal Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, due to the complementary action of drug combinations over mono-therapy, the multiple-drugs for multiple-targets paradigm has received increased attention to treat bacterial infections and complex diseases. Although new drug combinations screening has benefited from experimental tests like automated high throughput screening, it is limited due to the large number of possible drug combinations. The task of drug combination screening can be streamlined through computational methods and models. Such models require up-to-date databases; however, existing databases are static and consist of the data collected at the time of their creation. This paper introduces the Continuous Drug Combination Database (CDCDB), a continuously updated drug combination database. The CDCDB includes over 40,795 drug combinations, of which 17,107 are unique combinations consisting of more than 4,129 individual drugs, curated from ClinicalTrials.gov, the FDA Orange Book

Indexed as

Databases, FactualDrug CombinationsDrug DiscoveryHigh-Throughput Screening AssaysDrug Combinations

Identifiers

PMID35654801
PMCPMC9163158
OpenAlexW4281672524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.